Product Information
ATENOLOL-CHLORTHALIDONE 100-25 is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.3351 per EA under NDC 70710116801. Its NADAC has been published 383 times since Jun 5, 2019.
FDA first approved this application on Mar 8, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100; 25 mg/1; mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710116801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ATENOLOL; CHLORTHALIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA210028FDA Approved
3/8/2019
TE Code
AB
On Market Since
3/12/2019
Pharmacological Classes
Price Statistics
The NADAC for ATENOLOL-CHLORTHALIDONE 100-25 has been published 383 times since Jun 5, 2019, and over the history we have for it it has declined 43.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3351 per EA |
|---|---|
| All-time high | $0.6100 (Aug 14, 2019) |
| All-time low | $0.2780 (Nov 20, 2024) |
| 52-week high | $0.3790 |
| 52-week low | $0.3321 |
| Median price | $0.4356 |
| Average price | $0.4554 |
| Largest weekly change | -28.4% (Nov 20, 2024) |
| Weeks tracked | 383 |
| Tracking since | Jun 5, 2019 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Atenolol and Chlorthalidone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Thiazide-like Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATENOLOL-CHLORTHALIDONE 100-25?
The current National Average Drug Acquisition Cost (NADAC) for ATENOLOL-CHLORTHALIDONE 100-25, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.3351 per EA (NDC 70710116801), effective Sep 30, 2026.
How has the price of ATENOLOL-CHLORTHALIDONE 100-25 changed over time?
Over the history we have for it, the NADAC for ATENOLOL-CHLORTHALIDONE 100-25 has declined 43.4%. It has been tracked across 383 weekly CMS publications since Jun 5, 2019.
What are the highest and lowest recorded NADAC prices for ATENOLOL-CHLORTHALIDONE 100-25?
Since Jun 5, 2019, the NADAC for ATENOLOL-CHLORTHALIDONE 100-25 has ranged from a low of $0.2780 (Nov 20, 2024) to a high of $0.6100 (Aug 14, 2019), with a median of $0.4356 per EA.
Are there cheaper alternatives to ATENOLOL-CHLORTHALIDONE 100-25?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATENOLOL-CHLORTHALIDONE 100-25 in a comparable dosage form, but none are currently priced below it.
Who manufactures ATENOLOL-CHLORTHALIDONE 100-25?
ATENOLOL-CHLORTHALIDONE 100-25 (NDC 70710116801) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.